This article first appeared on GuruFocus .
-
Revenue:EUR259 million, an increase of 28.1%.
-
Organic Growth:Approximately 5%.
-
Profitability:18.6%, increased by 30.8% year-over-year.
-
Comparable EBITA Margin:7.2%, up by 0.2% from last year.
-
Earnings Per Share (EPS):EUR0.17.
-
Order Wins:EUR72 million, a record number for Scanfil.
-
Net Debt:EUR139.6 million with a leverage rate of 1.6x.
-
Equity Ratio:41.6%.
-
Return on Equity:13%.
-
Operating Cash Flow:EUR5.9 million for the first half of the year.
-
Available Liquidity:EUR170 million in unused credit limits and loan facilities.
-
Warning! GuruFocus has detected 6 Warning Signs with STU:S0A.
-
Is STU:S0A fairly valued? Test your thesis with our free DCF calculator.
Release Date: July 16, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
Scanfil PLC ( STU:S0A ) reported a strong Q2 2026 with a 28.1% increase in revenue, driven by both organic growth and acquisitions.
-
The company achieved its highest Net Promoter Score (NPS) ever, indicating strong customer satisfaction and commitment.
-
Significant new contracts were secured, including a EUR25 million annual deal in the Energy & Cleantech sector and a partnership with Bruker in Medtech & Life Science.
-
The expansion of the Suzhou facility is underway, expected to support future growth and meet increasing customer demand.
-
The company's profitability improved with a 30.8% increase in EBITA and a margin of 7.2%, reflecting efficient execution and cost management.
Negative Points
-
Net working capital increased due to higher business volumes, particularly in accounts receivable, which could impact cash flow.
-
The Industrial segment experienced a 45% decline in project wins, indicating potential demand softening or strategic withdrawal from certain deals.
-
Supply chain challenges were noted, particularly with memory components experiencing price increases.
-
The company's leverage ratio increased to 1.6x due to acquisition financing, slightly above the long-term target of 1.5x.
-
Organic growth in the APAC region was relatively flat at 1%, highlighting potential challenges in achieving growth targets in this area.
Q & A Highlights
Q: Can you provide more details on the changes in net working capital and its impact on cash flow this quarter? Is this increase a permanent change due to Aerospace & Defense? A: Iiris Heiskanen, CFO : The increase in net working capital is driven by volume and organic growth, particularly in accounts receivables due to higher sales levels. While we expect improvements in the second half, the growing business volumes may keep working capital requirements high. Christophe Sut, CEO : In Aerospace & Defense, there is a different profile, but we see areas for improvement and can balance the situation.
Q: Are projects in Aerospace & Defense typically longer-term compared to other fields? A: Christophe Sut, CEO : Yes, projects in Aerospace & Defense tend to be longer-term commitments and prospects, which is a different profile compared to other fields.
Q: How do you see the development of Aerospace & Defense globally in the future? A: Christophe Sut, CEO : We have three growth drivers: Energy & Cleantech, Medtech, and Aerospace & Defense. We are proactive in developing these segments while maintaining a balanced portfolio. The outlook is positive with strong delivery and future opportunities.
Q: Have you reached a new plateau in deals won for Medtech & Life Sciences? A: Christophe Sut, CEO : Yes, we have reached a new plateau in the last eight months due to focused efforts over the past three years. This positions us for a different revenue dimension in this customer group.
Q: Are there any challenges with the supply of components like PCBs and memories? A: Christophe Sut, CEO : The situation has become more tense, especially with memory prices increasing. However, we have good supplier relationships and have managed the situation well, keeping it under control.
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
